Matthew Dilallo is a contributing writer at Fool.com. He covers a range of topics including markets, IPOs, and the oil and gas sector, with a particular focus on companies like Chevron and real estate trends. His work has been featured in Yahoo Finance, Nasdaq, and The Motley Fool.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Matthew Dilallo’s articles primarily focus on investment analysis, with a significant emphasis on energy and real estate industries. He also frequently provides guides on investing in specific stocks and dividends.
If you are looking to pitch to Matthew, consider offering in-depth analysis of potential investments within the energy or real estate sectors. Additionally, if you have expertise in identifying dividend opportunities or insights into IPOs that align with his coverage areas, your pitch may be well received.
Remember that Matthew does not appear to have a specific geographic focus but instead focuses on providing valuable investment advice across various markets.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Matthew DiLallo
Key Points Eli Lilly is a leading global pharmaceutical company. It has developed several blockbuster drugs. It could have another blockbuster on its hands with weight loss drug Zepbound. Motley Fool Issues Rare “All In” Buy Alert The sales potential of Zepbound and the company's other drugs have many investors interested in the stock. Here's everything you need to know about how to invest in Eli Lilly.
Novo Nordisk is a leading global healthcare company. Its breakthrough medications to treat type 2 diabetes and weight loss, including Ozempic and Wegovy, have many people wondering how to invest in the company. Here's what you should know.
Boston Dynamics is a global leader in developing highly mobile robots, with more real-world experience than any other robot developer. Here's what you should know about investing in the company.
A short strangle is an options trading strategy that involves selling a call option and a put option on the same underlying stock with the same expiration date. This article explains what that could mean for you.
Key Points Bank of New York Mellon is a publicly traded company owned by its shareholders. It was the first company to ever go public on the New York Stock Exchange. Institutional investors own most of its stock. 10 stocks we like better than Bank Of New York Mellon
Corporate travel and expense company Navan isn't publicly traded yet. Learn about investing in Navan and the latest news on its anticipated IPO.
With its rapid growth and Google's interest, Wiz will likely be a hot IPO. Here's a look at the company and how you can cash in.
Key Points Lineage Logistics, the world's largest cold storage operator, went public with a $4.4 billion IPO in July 2024. Now publicly traded, Lineage can be bought in any brokerage account via the stock ticker LINE. Investors can consider Lineage for its dividend and growth potential in the logistics sector. Motley Fool Issues Rare “All In” Buy Alert Key findings are powered by ChatGPT and based solely off the content from this article. Findings are reviewed by our editorial team. The author and editors take ultimate responsibility for the content.
By Matthew DiLallo – Updated Mar 8, 2025 at 10:00PM Key Points The iShares 20+ Year Treasury Bond ETF offers access to long-term U.S. Treasuries through one fund.
(833) 317-6278 
